Diabeloop - Key Player in Therapeutic AI Applied to Insulin Delivery - Announces 70 Million Euros New Financing Round to Accelerate Its International Expansion
June 02, 2022 08:30 ET
|
Diabeloop SA
PARIS, June 02, 2022 (GLOBE NEWSWIRE) -- Diabeloop secures 70 million euros to pursue its solid and sustained growth strategy. The automated insulin delivery pioneer, develops machine-learning...
eureKARE participates in DNA Script’s $200 Million Series C Financing
January 04, 2022 06:21 ET
|
eureKARE
eureKARE participates in DNA Script’s $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France –...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 07:00 ET
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide
May 27, 2021 02:00 ET
|
Jeito Capital
Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 02:00 ET
|
Pulmocide
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
AZTherapies Closes $26.3 Million Series C Preferred Equity Financing
October 17, 2019 08:32 ET
|
AZTherapies, Inc.
BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the closing of a $26.3 million Series C...
SPR Therapeutics® Secures $25 Million in Series C Financing
September 12, 2017 08:03 ET
|
SPR Therapeutics, LLC
CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain,...
Colibri Heart Valve Enters Agreement with Venus Medtech to Form Joint Venture to Develop Next-Generation Transcatheter Heart Valve Technologies
September 13, 2016 08:00 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, has entered into definitive...